FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Federal Register

Workshop on Kidney Transplant Rejection Drugs

Federal Register Notice: FDA announces a 4/12 public workshop on new developments and scientific issues related to antibody mediated rejection in kidn...

Federal Register

FDA/Xavier University Medical Device Conference

Federal Register Notice: FDA co-sponsors with Xavier University a public conference entitled FDA/Xavier University Medical Device Conference.

Federal Register

Cedax Not Withdrawn Over Safety or Effectiveness

Federal Register Notice: FDA determines that Pernix Therapeutics antibiotic Cedax (ceftibuten dihydrate) for oral suspension, 90mg/5mL and 180mg/5mL, ...

Human Drugs

Medtronic Field Correction for Newport Ventilators

Medtronic issues a field corrective action for all Newport HT70 and Newport HT70 Plus ventilators manufactured since 2010 due to reports that the vent...

FDA General

Gottlieb Criticized on Industry Ties at Nomination Hearing

Faced with harsh criticism from Democrats about his ties to regulated industry, FDA commissioner nominee Scott Gottlieb tells members of the Senate He...

FDA General

Markey, Brown Oppose Gottlieb Nomination

Sens. Markey and Brown say they oppose the nomination of Scott Gottlieb to be FDA commissioner because he will not effectively use FDA to battle the n...

Medical Devices

FDA Clears VivaLnk Wearable Remote Thermometer

FDA clears a VivaLnk 510(k) for the Fever Scout, a soft, wearable thermometer that continuously measures a persons temperature.

Human Drugs

Amgen sBLA for Xgeva Expanded Indication

Amgen files a supplemental BLA for Xgeva (denosumab) to expand its use for preventing skeletal-related events in solid tumors to include patients with...

Human Drugs

FDA Cites Clinical Investigator Lapses

FDA warns clinical investigator Cassandra Curtis about violations in a Pfizer Chantix study.

Human Drugs

11 Drug Risk Signals in 2016 4th Quarter

FDA publishes a list of 11 drugs or classes of drugs for which potential signals of serious risks/new safety information were identified in the 4th qu...